Lipids and HCV
MF Bassendine, DA Sheridan, SH Bridge… - Seminars in …, 2013 - Springer
Chronic hepatitis C virus (HCV) infection is associated with an increase in hepatic steatosis
and a decrease in serum levels of total cholesterol, low-density lipoprotein cholesterol (LDL) …
and a decrease in serum levels of total cholesterol, low-density lipoprotein cholesterol (LDL) …
Hepatic steatosis in human immunodeficiency virus: a prospective study in patients without viral hepatitis, diabetes, or alcohol abuse
RK Sterling, PG Smith, EM Brunt - Journal of clinical …, 2013 - journals.lww.com
Methods: HIV-positive subjects without hepatitis C virus, hepatitis B virus, alcohol abuse,
and diabetes mellitus with more than 1 abnormal LE, defined as 1.25 ULN in aspartate …
and diabetes mellitus with more than 1 abnormal LE, defined as 1.25 ULN in aspartate …
Absence of liver steatosis in HIV–HCV co-infected patients receiving regimens containing tenofovir or abacavir
Background In human immunodeficiency virus–hepatitis C virus (HIV–HCV) co-infected
patients, steatosis has been independently associated with a number of antiretroviral drugs …
patients, steatosis has been independently associated with a number of antiretroviral drugs …
Hepatotoxicity of antiviral agents
M Núñez - Drug-induced liver disease, 2013 - Elsevier
Antiretroviral drugs, targeting the human immune deficiency virus, are the antivirals that
more often cause drug-induced liver injury (DILI). DILI secondary to antiretroviral use is …
more often cause drug-induced liver injury (DILI). DILI secondary to antiretroviral use is …
[PDF][PDF] DOCTORAT EN SANTE PUBLIQUE: EPIDEMIOLOGIE ET SCIENCES DE L'INFORMATION BIOMEDICALE
PDELIVHC ET - 2013 - Citeseer
Avec l'introduction des inhibiteurs de protéase en 1996, l'espérance de vie des patients
infectés par le VIH augmenta du fait d'une diminution importante de la morbidité et de la …
infectés par le VIH augmenta du fait d'une diminution importante de la morbidité et de la …